We did notice that a high CD70+ CAF score was mostly present in samples from PDAC patients with an advanced disease stage, but the lack of adequate PDAC tumor samples from stage T1NxMx and T4NxMx is a drawback in this study. This evidence concerns the gene CD70 and neoplasm.